CC BY-NC-ND 4.0 · Journal of Coloproctology 2021; 41(02): 198-205
DOI: 10.1055/s-0041-1724055
Review Article

Robotic Surgery in Rectal Cancer[*]

Cirurgia robótica no cancro do reto
1   Universidade do Porto, Faculdade de Medicina, Porto, Portugal
,
1   Universidade do Porto, Faculdade de Medicina, Porto, Portugal
2   Hospital de São João, Serviço de Cirurgia Geral, Porto, Portugal
› Author Affiliations

Abstract

Rectal cancer is an important cause of morbidity and mortality worldwide. The most effective and curative treatment is surgery, and the standard procedure is total mesorectal excision, initially performed by open surgery and posteriorly by minimally invasive techniques. Robotic surgery is an emerging technology that is expected to overcome the limitations of the laparoscopic approach. It has several advantages, including a stable camera platform with high definition three-dimensional image, flexible instruments with seven degrees of freedom, a third arm for fixed retraction, fine motion scaling, excellent dexterity, ambidextrous capability, elimination of physiological tremors and better ergonomics, that facilitate a steady and precise tissue dissection. The main technical disadvantages are the loss of tactile sensation and tensile feedback and the complex installation process. The aim of the present study is to review the importance and benefits of robotic surgery in rectal cancer, particularly in comparison with the laparoscopic approach. Intraoperative estimated blood loss, short and long-term outcomes as well as pathological outcomes were similar between robotic and laparoscopic surgery. The operative time is usually longer in robotic surgery and the high costs are still its major drawback. Robotic surgery for rectal cancer demonstrated lower conversion rate to open surgery and benefits in urinary and sexual functions and has been established as a safe and feasible technique.

Resumo

O cancro do reto é uma importante causa de morbidade e mortalidade em todo o mundo. O único tratamento curativo e mais eficaz é a cirurgia, sendo que o procedimento padrão é a excisão total do mesoreto, inicialmente realizada por cirurgia aberta e mais tarde por técnicas minimamente invasivas. A cirurgia robótica é uma tecnologia emergente que pretende ultrapassar as limitações da laparoscopia. As vantagens incluem plataforma de câmera estável, imagem tridimensional com alta definição, instrumentos flexíveis com sete graus de liberdade, terceiro braço para retração fixa, movimentos finos, excelente destreza, ambidestria, eliminação do tremor fisiológico e maior conforto ergonômico, que facilitam uma disseção firme e precisa dos tecidos. As principais desvantagens técnicas são a perda da sensação táctil e feedback tensional e o complexo processo de instalação. O objetivo deste estudo é fazer uma revisão bibliográfica da importância e dos benefícios da cirurgia robótica no cancro do reto, particularmente em comparação com a cirurgia laparoscópica. A perda estimada de sangue intraoperatória, os outcomes a curto e longo-prazo e os outcomes patológicos foram equivalentes entre a cirurgia robótica e laparoscópica. O tempo operatório é geralmente mais longo na cirurgia robótica e os elevados custos são a sua principal desvantagem. A cirurgia robótica no cancro do reto demonstrou menor taxa de conversão para cirurgia aberta e benefícios nas funções urinária e sexual e está estabelecida como uma técnica segura e viável.

* Study conducted at Universidade do Porto, Faculdade de Medicina, Departamento de Cirurgia Geral, Porto, Portugal




Publication History

Received: 08 June 2020

Accepted: 30 August 2020

Article published online:
24 May 2021

© 2021. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Global Cancer Observatory. Cancer Today [Internet]. Lyon, France: International Agency for Research on Cancer. [cited 2020 Jan 18]. Available from: https://gco.iarc.fr/today
  • 2 Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?. Br J Surg 1982; 69 (10) 613-616
  • 3 Tomassi MJ, Taller J, Yuhan R, Ruan JH, Klaristenfeld DD. Robotic transanal minimally invasive surgery for the excision of rectal neoplasia: Clinical experience with 58 consecutive patients. Dis Colon Rectum 2019; 62 (03) 279-285
  • 4 Vignali A, Elmore U, Milone M, Rosati R. Transanal total mesorectal excision (TaTME): current status and future perspectives. Updates Surg 2019; 71 (01) 29-37
  • 5 Lee L, de Lacy B, Gomez Ruiz M. et al. A multicenter matched comparison of transanal and robotic total mesorectal excision for mid and low-rectal adenocarcinoma. Ann Surg 2019; 270 (06) 1110-1116
  • 6 Jones K, Qassem MG, Sains P, Baig MK, Sajid MS. Robotic total meso-rectal excision for rectal cancer: A systematic review following the publication of the ROLARR trial. World J Gastrointest Oncol 2018; 10 (11) 449-464
  • 7 Wells KO, Peters WR. Minimally invasive surgery for locally advanced rectal cancer. Surg Oncol Clin N Am 2019; 28 (02) 297-308
  • 8 Nozawa H, Watanabe T. Robotic surgery for rectal cancer. Asian J Endosc Surg 2017; 10 (04) 364-371
  • 9 Li X, Wang T, Yao L. et al. The safety and effectiveness of robot-assisted versus laparoscopic TME in patients with rectal cancer: A meta-analysis and systematic review. Medicine (Baltimore) 2017; 96 (29) e7585
  • 10 Law WL, Foo DCC. Comparison of short-term and oncologic outcomes of robotic and laparoscopic resection for mid- and distal rectal cancer. Surg Endosc 2017; 31 (07) 2798-2807
  • 11 Schmiegelow AFT, Broholm M, Gögenur I, Fode M. Evaluation of sexual and urinary function after implementation of robot-assisted surgery for rectal cancer: A single-center study. Surg Laparosc Endosc Percutan Tech 2016; 26 (02) 141-145
  • 12 Wang G, Wang Z, Jiang Z, Liu J, Zhao J, Li J. Male urinary and sexual function after robotic pelvic autonomic nerve-preserving surgery for rectal cancer. Int J Med Robot 2017;13(01):
  • 13 Ishihara S, Otani K, Yasuda K. et al. Recent advances in robotic surgery for rectal cancer. Int J Clin Oncol 2015; 20 (04) 633-640
  • 14 Alsowaina KN, Schlachta CM, Alkhamesi NA. Cost-effectiveness of current approaches in rectal surgery. Ann Med Surg (Lond) 2019; 45: 36-39
  • 15 Hoshino N, Sakamoto T, Hida K, Sakai Y. Robotic versus laparoscopic surgery for rectal cancer: an overview of systematic reviews with quality assessment of current evidence. Surg Today 2019; 49 (07) 556-570
  • 16 Kim CN, Bae SU, Lee SG. et al. Clinical and oncologic outcomes of totally robotic total mesorectal excision for rectal cancer: initial results in a center for minimally invasive surgery. Int J Colorectal Dis 2016; 31 (04) 843-852
  • 17 Grass JK, Perez DR, Izbicki JR, Reeh M. Systematic review analysis of robotic and transanal approaches in TME surgery- A systematic review of the current literature in regard to challenges in rectal cancer surgery. Eur J Surg Oncol 2019; 45 (04) 498-509
  • 18 Huang YJ, Kang YN, Huang YM, Wu AT, Wang W, Wei PL. Effects of laparoscopic vs robotic-assisted mesorectal excision for rectal cancer: An update systematic review and meta-analysis of randomized controlled trials. Asian J Surg 2019; 42 (06) 657-666
  • 19 Ohtani H, Maeda K, Nomura S. et al. Meta-analysis of robot-assisted versus laparoscopic surgery for rectal cancer. In Vivo 2018; 32 (03) 611-623
  • 20 Ahmed J, Cao H, Panteleimonitis S, Khan J, Parvaiz A. Robotic vs laparoscopic rectal surgery in high-risk patients. Colorectal Dis 2017; 19 (12) 1092-1099
  • 21 Valverde A, Goasguen N, Oberlin O. et al. Robotic versus laparoscopic rectal resection for sphincter-saving surgery: pathological and short-term outcomes in a single-center analysis of 130 consecutive patients. Surg Endosc 2017; 31 (10) 4085-4091
  • 22 Chen ST, Wu MC, Hsu TC. et al; Health Economics and Outcome Research Group, National Taiwan University Hospital. Comparison of outcome and cost among open, laparoscopic, and robotic surgical treatments for rectal cancer: A propensity score matched analysis of nationwide inpatient sample data. J Surg Oncol 2018; 117 (03) 497-505
  • 23 Sun XY, Xu L, Lu JY, Zhang GN. Robotic versus conventional laparoscopic surgery for rectal cancer: systematic review and meta-analysis. Minim Invasive Ther Allied Technol 2019; 28 (03) 135-142
  • 24 Sugoor P, Verma K, Chaturvedi A. et al. Robotic versus laparoscopic sphincter-preserving total mesorectal excision: A propensity case-matched analysis. Int J Med Robot 2019; 15 (01) e1965
  • 25 Prete FP, Pezzolla A, Prete F. et al. Robotic versus laparoscopic minimally invasive surgery for rectal cancer: A systematic review and meta-analysis of randomized controlled trials. Ann Surg 2018; 267 (06) 1034-1046
  • 26 Alfieri S, Di Miceli D, Menghi R. et al. Single-docking full robotic surgery for rectal cancer: A single-center experience. Surg Innov 2018; 25 (03) 258-266
  • 27 Mégevand JL, Lillo E, Amboldi M, Lenisa L, Ambrosi A, Rusconi A. TME for rectal cancer: consecutive 70 patients treated with laparoscopic and robotic technique-cumulative experience in a single centre. Updates Surg 2019; 71 (02) 331-338
  • 28 Li L, Zhang W, Guo Y. et al. Robotic versus laparoscopic rectal surgery for rectal cancer: A meta-analysis of 7 randomized controlled trials. Surg Innov 2019; 26 (04) 497-504
  • 29 Quero G, Rosa F, Ricci R. et al. Open versus minimally invasive surgery for rectal cancer: a single-center cohort study on 237 consecutive patients. Updates Surg 2019; 71 (03) 493-504
  • 30 Tang B, Zhang C, Li C. et al. Robotic total mesorectal excision for rectal cancer: A series of 392 cases and mid-term outcomes from a single center in china. J Gastrointest Surg 2017; 21 (03) 569-576
  • 31 Tsukamoto S, Nishizawa Y, Ochiai H. et al. Surgical outcomes of robot-assisted rectal cancer surgery using the da Vinci Surgical System: a multi-center pilot Phase II study. Jpn J Clin Oncol 2017; 47 (12) 1135-1140
  • 32 Matsuyama T, Kinugasa Y, Nakajima Y, Kojima K. Robotic-assisted surgery for rectal cancer: Current state and future perspective. Ann Gastroenterol Surg 2018; 2 (06) 406-412
  • 33 Lee SG, Russ AJ, Casillas Jr MA. Laparoscopic transanal minimally invasive surgery (L-TAMIS) versus robotic TAMIS (R-TAMIS): short-term outcomes and costs of a comparative study. Surg Endosc 2019; 33 (06) 1981-1987
  • 34 Huang YJ, Huang YM, Wang WL, Tong YS, Hsu W, Wei PL. Surgical outcomes of robotic transanal minimally invasive surgery for selected rectal neoplasms: A single-hospital experience. Asian J Surg 2020; 43 (01) 290-296
  • 35 Ishihara S, Kiyomatsu T, Kawai K. et al. The short-term outcomes of robotic sphincter-preserving surgery for rectal cancer: comparison with open and laparoscopic surgery using a propensity score analysis. Int J Colorectal Dis 2018; 33 (08) 1047-1055
  • 36 Crolla RMPH, Mulder PG, van der Schelling GP. Does robotic rectal cancer surgery improve the results of experienced laparoscopic surgeons? An observational single institution study comparing 168 robotic assisted with 184 laparoscopic rectal resections. Surg Endosc 2018; 32 (11) 4562-4570
  • 37 Feroci F, Vannucchi A, Bianchi PP. et al. Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery. World J Gastroenterol 2016; 22 (13) 3602-3610
  • 38 Jayne D, Pigazzi A, Marshall H. et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: The ROLARR randomized clinical trial. JAMA 2017; 318 (16) 1569-1580
  • 39 Ielpo B, Duran H, Diaz E. et al. Robotic versus laparoscopic surgery for rectal cancer: a comparative study of clinical outcomes and costs. Int J Colorectal Dis 2017; 32 (10) 1423-1429
  • 40 Liao G, Li YB, Zhao Z, Li X, Deng H, Li G. Robotic-assisted surgery versus open surgery in the treatment of rectal cancer: the current evidence. Sci Rep 2016; 6: 26981
  • 41 Xiong B, Ma L, Huang W, Zhao Q, Cheng Y, Liu J. Robotic versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of eight studies. J Gastrointest Surg 2015; 19 (03) 516-526
  • 42 Wang Y, Zhao GH, Yang H, Lin J. A pooled analysis of robotic versus laparoscopic surgery for total mesorectal excision for rectal cancer. Surg Laparosc Endosc Percutan Tech 2016; 26 (03) 259-264
  • 43 Sun Y, Xu H, Li Z. et al. Robotic versus laparoscopic low anterior resection for rectal cancer: a meta-analysis. World J Surg Oncol 2016; 14: 61
  • 44 Melstrom K. Robotic rectal cancer surgery. Cancer Treat Res 2016; 168: 295-308
  • 45 Kwak JM, Kim SH. Robotic surgery for rectal cancer: An update in 2015. Cancer Res Treat 2016; 48 (02) 427-435
  • 46 Rouanet P, Bertrand MM, Jarlier M. et al. Robotic versus laparoscopic total mesorectal excision for sphincter-saving surgery: Results of a single-center series of 400 consecutive patients and perspectives. Ann Surg Oncol 2018; 25 (12) 3572-3579
  • 47 Bedirli A, Salman B, Yuksel O. Robotic versus laparoscopic resection for mid and low rectal cancers. JSLS 2016; 20 (01) e2015.00110
  • 48 Lee SH, Kim DH, Lim SW. Robotic versus laparoscopic intersphincteric resection for low rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 2018; 33 (12) 1741-1753
  • 49 Lee SH, Lim S, Kim JH, Lee KY. Robotic versus conventional laparoscopic surgery for rectal cancer: systematic review and meta-analysis. Ann Surg Treat Res 2015; 89 (04) 190-201
  • 50 Hopkins MB, Geiger TM, Bethurum AJ. et al. Comparing pathologic outcomes for robotic versus laparoscopic Surgery in rectal cancer resection: a propensity adjusted analysis of 7616 patients. Surg Endosc 2020; 34 (06) 2613-2622
  • 51 Lee GI, Lee MR, Clanton T, Sutton E, Park AE, Marohn MR. Comparative assessment of physical and cognitive ergonomics associated with robotic and traditional laparoscopic surgeries. Surg Endosc 2014; 28 (02) 456-465
  • 52 van der Schatte Olivier RH, Van't Hullenaar CDP, Ruurda JP, Broeders IAMJ. Ergonomics, user comfort, and performance in standard and robot-assisted laparoscopic surgery. Surg Endosc 2009; 23 (06) 1365-1371
  • 53 Zihni AM, Ohu I, Cavallo JA, Cho S, Awad MM. Ergonomic analysis of robot-assisted and traditional laparoscopic procedures. Surg Endosc 2014; 28 (12) 3379-3384
  • 54 Tarr ME, Brancato SJ, Cunkelman JA, Polcari A, Nutter B, Kenton K. Comparison of postural ergonomics between laparoscopic and robotic sacrocolpopexy: a pilot study. J Minim Invasive Gynecol 2015; 22 (02) 234-238
  • 55 Hubert N, Gilles M, Desbrosses K, Meyer JP, Felblinger J, Hubert J. Ergonomic assessment of the surgeon's physical workload during standard and robotic assisted laparoscopic procedures. Int J Med Robot 2013; 9 (02) 142-147
  • 56 Pigazzi A, Ellenhorn JDI, Ballantyne GH, Paz IB. Robotic-assisted laparoscopic low anterior resection with total mesorectal excision for rectal cancer. Surg Endosc 2006; 20 (10) 1521-1525
  • 57 Asklid D, Gerjy R, Hjern F, Pekkari K, Gustafsson UO. Robotic vs laparoscopic rectal tumour surgery: a cohort study. Colorectal Dis 2019; 21 (02) 191-199
  • 58 Eskicioglu C, Forbes SS, Aarts MA, Okrainec A, McLeod RS. Enhanced recovery after surgery (ERAS) programs for patients having colorectal surgery: a meta-analysis of randomized trials. J Gastrointest Surg 2009; 13 (12) 2321-2329
  • 59 Bo T, Chuan L, Hongchang L, Chao Z, Huaxing L, Peiwu Y. Robotic versus laparoscopic rectal resection surgery: Short-term outcomes and complications: A retrospective comparative study. Surg Oncol 2019; 29: 71-77
  • 60 Corbellini C, Biffi R, Luca F. et al. Open, laparoscopic, and robotic surgery for rectal cancer: medium-term comparative outcomes from a multicenter study. Tumori 2016; 102 (04) 414-421
  • 61 Chang W, Wei Y, Ren L. et al. Short-term and long-term outcomes of robotic rectal surgery - from the real word data of 1145 consecutive cases in China. Surg Endosc 2019
  • 62 Liao G, Zhao Z, Deng H, Li X. Comparison of pathological outcomes between robotic rectal cancer surgery and laparoscopic rectal cancer surgery: A meta-analysis based on seven randomized controlled trials. Int J Med Robot 2019; 15 (05) e2027
  • 63 Esen E, Aytac E, Ağcaoğlu O. et al. Totally robotic versus totally laparoscopic surgery for rectal cancer. Surg Laparosc Endosc Percutan Tech 2018; 28 (04) 245-249
  • 64 de Jesus JP, Valadão M, de Castro Araujo RO, Cesar D, Linhares E, Iglesias AC. The circumferential resection margins status: A comparison of robotic, laparoscopic and open total mesorectal excision for mid and low rectal cancer. Eur J Surg Oncol 2016; 42 (06) 808-812
  • 65 Milone M, Manigrasso M, Velotti N. et al. Completeness of total mesorectum excision of laparoscopic versus robotic surgery: a review with a meta-analysis. Int J Colorectal Dis 2019; 34 (06) 983-991
  • 66 Kim HJ, Choi GS, Park JS, Park SY, Yang CS, Lee HJ. The impact of robotic surgery on quality of life, urinary and sexual function following total mesorectal excision for rectal cancer: a propensity score-matched analysis with laparoscopic surgery. Colorectal Dis 2018; 20 (05) O103-O113
  • 67 Tang X, Wang Z, Wu X, Yang M, Wang D. Robotic versus laparoscopic surgery for rectal cancer in male urogenital function preservation, a meta-analysis. World J Surg Oncol 2018; 16 (01) 196
  • 68 Broholm M, Pommergaard HC, Gögenür I. Possible benefits of robot-assisted rectal cancer surgery regarding urological and sexual dysfunction: a systematic review and meta-analysis. Colorectal Dis 2015; 17 (05) 375-381
  • 69 Ramallo-Solis I, Jimenez-Rodriguez RM, Reyes-Diaz ML. et al. Influence of robotics in surgical complication rate in elderly population with rectal cancer. Aging Clin Exp Res 2019